
- BioPharm International, September 2021 Issue
- Volume 34
- Issue 9
Conformational and Colloidal Stability Studies to Predict the Best Biopharmaceutical Formulation
Establishing analytical workflows for complex biopharmaceutical molecules can help predict their risk of degradation.
Biopharmaceuticals are complex molecules with a variety of functional groups that are susceptible to instability through different degradation pathways. Protein degradation may arise as a result of exposure to different environmental changes and stresses throughout the product lifecycle. Molecular variants arising during manufacture and/or storage may not have properties comparable to those of the desired product with respect to their activity, efficacy, and most importantly, safety. Therefore, it is crucial to set up analytical workflows to understand the intrinsic biochemical and physical stability of these molecules and predict the risk of degradants formation. This paper describes the application of biophysical stability parameters that measure solution-mediated interactions and key structural characteristics of model proteins that will enable a fast assessment of conformational and colloidal stability of biopharmaceuticals.
Click
for a PDF of this article.
Peer-Reviewed
Submitted: Feb. 24, 2021
Accepted: April 9, 2021
About the authors
Joana S. Cristóvão*, PhD, jscristovao@hovione.com, is an analytical scientist, and Salomé Neto was a Master’s student, both with Hovione Farmaciência S.A., R&D, Analytical Development.
*To whom all correspondence should be addressed.
Article Details
BioPharm International
Vol. 34, No. 9
September 2021
Pages: 34–40
Citation
When referring to this article, please cite it as J.S. Cristóvão and S. Neto, “Conformational and Colloidal Stability Studies to Predict the Best Biopharmaceutical Formulation,” BioPharm International 34 (9) 34–40 (2021).
Articles in this issue
about 4 years ago
Setting a Clear Strategy for Primary Packagingabout 4 years ago
Bioprocessing Innovations Pose New Challenges for Fermentationabout 4 years ago
Process Chromatography Makes Steady Progressabout 4 years ago
Reevaluating Cell and Gene Therapy Developmentabout 4 years ago
Using Digital Twins to Model Process Chromatographyabout 4 years ago
Opportunities for Digital Twinsabout 4 years ago
How Pure is Pure? Understanding Reagent Purity Gradesabout 4 years ago
The Impact of Insufficient Oversightabout 4 years ago
In Vitro Pulls Ahead of In Vivo for Adventitious Agent Testingabout 4 years ago
Trends Affecting Biopharmaceutical ManufacturingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.